actelion ltd net profit nearly doubles on strong sales of tracleer actelion ltd said second quarter net profit nearly doubled and the switzerland based pharmaceutical company raised its revenue forecast for the year on the back of soaring sales of its flagship drug tracleer actelion said net profit jumped to million swiss francs &# million from million francs a year earlier as the company was able to keep a lid on its costs actelion shares rose francs or to francs in zurich trading sales rose to million francs as the companys pulmonary arterial hypertension drug tracleer continued to gather momentum despite the launch of competing drugs actelion now targets total revenue for of billion francs to billion francs 
